Dr David Torstensson and U.S. Chamber of Commerce launch new fourth edition of the Global Rule of Law and Business Dashboard

Posted by:

Last week Dr David Torstensson presented the findings of the 2019 Global Rule of Law and Business Dashboard at the U.S. Chamber of Commerce in Washington D.C.

Titled Laying the Foundation for Prosperity the Dashboard offers the business community, governments, policymakers and stakeholders across the world an innovative, empirical tool to measure and understand the particular needs of the business community within a rule of law context. What are the issues that are important to business? What is currently being measured internationally? And what does this tell us ...

Continue Reading →
0

Towards a sustainable European market for off-patent biologics

Posted by:

As pioneers with regards to the regulatory approval and use of biosimilars, the EU is now reaping the economic benefits, with increased patient access and healthcare system efficiencies generated through competition on the one hand and continued innovation on the other – an essential equilibrium for securing a sustainable future for the European biologics market.

However, the increasing focus on maximizing short-term savings and the high diversity of policies governing the daily practice of off-patent biologics may eventually undermine this goal.

It is imperative to ask: How should the policy ...

Continue Reading →
0

Never stop reforming – six editions of Building the Bioeconomy has clear message to biotechnology policymakers around the world

Posted by:

This week I am having the pleasure of attending the 2019 BIO International Convention hosted in Philadelphia, Pennsylvania. The biggest global event of its kind, this international convention brings together stakeholders from across the biotechnologies. Whether it be from the health, agricultural or industrial sector, anyone who is anyone in biotech is in Philadelphia this week.

Every year I come to the Convention I am struck by the sheer growth in numbers. More participants; more international delegations; more interest in biotech. ...

Continue Reading →
0

Pugatch Consilium is releasing the sixth edition of the Building the Bioeconomy

Posted by:

Pugatch Consilium is today releasing the sixth edition of the Building the Bioeconomy, a series of papers commissioned by the Biotechnology Industry Organization. Since 2013, the series has taken the pulse of biotechnology policies in the main economies worldwide, and has shown that policy choices are key determinants of success in growing biotechnology sectors.
This year’s edition adds to the analysis eleven countries, further increasing the geographic and economic diversity of the countries sampled. Yet, the findings of the report ...

Continue Reading →
0

Taiwan is accelerating towards leadership of the Fourth Industrial Revolution

Posted by:

Professor Meir Pugatch spoke last week at the forum “How to Accelerate Taiwan Biomedical Policy Momentum as an Asia-Pacific Biomedical R&D Hub” hosted by the International Research-based Pharmaceutical Manufacturers Association (IRPMA), and included the Vice President of Taiwan Chien-Jen Chen and Minister Ming-Hsin Kung from the Executive Yuan, as well as leading figures from Taiwan’s Government, academia and industry.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to, and remaining challenges in, Taiwan’s path to leadership in global ...

Continue Reading →
0

The EU Orphan Regulation: A success story in driving R&D of orphan medicines in the EU – but what about access?

Posted by:

Pugatch Consilium is today releasing a new study – Benchmarking Success: Evaluating the Orphan Regulation and its impact on patients and rare disease R&D in the European Union.

Within the context of the European Commission’s Evaluation of the legislation on medicines for children and rare diseases, the study examines whether the EU Orphan Regulation has accomplished its aim of incentivising the development and introduction of new therapies for rare diseases onto the EU market, and explores some of the current and ...

Continue Reading →
0

Positioning Ireland as a global innovation leader in the 4th Industrial Revolution

Posted by:

Professor Pugatch delivered a keynote presentation at the 25th Annual Conference of the Irish Pharmaceutical Healthcare Association (IPHA) at Dublin, Ireland, themed ‘Patient Care, Powered By Innovation’.

In the field of professional boxing, Ireland was and remains a global superpower and a role model. Yet in the field of biopharmaceutical innovation, Ireland does not step into the ring of greats:

  • Despite retaining the reputation of a global leader in advances biopharmaceutical manufacturing – with €10 billion invested over the past decade – ...
Continue Reading →
0

New Pugatch Consilium Study Shows How Countries Can Develop Biotech Industry

Posted by:

A Pugatch Consilium study released today commissioned by the Biotechnology Innovation Organization (BIO) highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world.

The fifth edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators ranging from public policy inputs to biotechnology outputs, the report provides a full and detailed ...

Continue Reading →
0

Leveraging Resources to Generate Outputs and Lead the Global Biotech Innovation – Policy is Key!

Posted by:

Most, if not all countries today view biotechnology as a strategic area for economic and social development and growth. Most, if not all countries today wish to leverage existing resources such as academic and research facilities and human capital to create a globally-competitive knowledge-based economy. Some have succeeded where others failed. Why?

 

Earlier last week Professor Meir Pugatch moderated the Global Leadership Forum at the BIO International Convention that was held at Boston, MA. The panel, titled “Can Boston’s DNA be ...

Continue Reading →
0

A New Era For Russian Biotechnology In 2030 – Remains To Be Seen And Proven

Posted by:

Professor Meir Pugatch spoke at the St. Petersburg International Economic Forum (SPIEF) in the panel: “Life Sciences in 2030: A New Era for Biotechnology” which took place on May 26, 2018 and included the Deputy Ministers of the Ministries of Health, Industry and Trade, and Agriculture of the Russian Federation, as well as Senior Executives of top MNCs in the private sector. Prof. Pugatch presented key highlights of Pugatch Consilium’s research concerning the enabling conditions for developing a competitive bioeconomy ...

Continue Reading →
0
Page 1 of 15 12345...»